DETAILS OF RESEARCH CONTRIBUTIONS
RESEARCH AND REVIEW PAPERS:
51.Chatterjee B, Almurisi SH, Dukhan AAM, Mandal UK, Sengupta P. (2016). Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view. Drug Delivery, 23(9), 3639-3652. [Impact Factor: 4.843]
50. Mandal UK, Chatterjee B, Senjoti FG. (2016). Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian Journal of Pharmaceutical Sciences,11, 575-584.
49. ChoudhuryH, GorainB, ChatterjeeB, MandalUK, Sengupta P, Tekade RK. (2016). Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route.Current Pharmaceutical Design, 12 (E-pub ahead of print). [Impact Factor: 3.052]
48. Sengupta P, DasA, Ibrahim F, Mandal UK, Chatterjee B, Mahmood S, DasSK, Kifayatullah M. (2016). Safety profiling of pioglitazone and telmisartan combination bysub-chronic toxicity study in rat. Regulatory Toxicology and Pharmacology, 81, 155-161. [Impact Factor: 2.031]
47. Ruzaidi AFB, Mandal UK, Chatterjee B. (2016). Glidant effect of hydrophobic and hydrophilic nano silica on a cohesive powder: Comparison among different flow characterization techniques. Particuology. [Impact factor: 2.110]
46. Abdul Manaf SA,Hedge G,Mandal UK,Wui WT,Roy P.Functionalized carbon nano-scale drug delivery systems from biowaste sago bark for cancer cell imaging.Current Drug Delivery. (Epub ahead of print). [Impact factor: 1.478]
45. Mahmood S, Hilmi NNB, Husain NKB, Chatterjee B, Mandal UK. (2016). Differential scanning calorimetric characterization of pharmaceutical powder blend uniformity in a laboratory-scale V-blender. Powder Technology, 287, 152–159. [Impact Factor: 2.349]
44. Senjoti FG, Mahmood S, Jaffri JM, Mandal UK. (2016). Design and In-vitro Evaluation of Sustained Release Floating Tablets of Metformin HCl Based on Effervescence and Swelling. Iranian Journal of Pharmaceutical Research, 15(1), 53-70.[Impact Factor: 1.065]
43. Oo MK, Mandal UK, Chatterjee B. (2016). Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. Pharmaceutical Development and Technology, Early Online, 1–11. [Impact factor: 1.20]
42. Mandal UK, Chatterjee B, Pauzi FHB. (2016). A Review on Transdermal Spray: Formulation Aspect. Mathews Journal of Pharmaceutical Science,1(1), 006.
41. Hegde G, Shanker G, Gan SM, Yuvaraj AR, Mahmood S, Mandal UK. (2016). Synthesis and liquid crystalline behavior of substituted (E)-phenyl-4-(phenyldiazenyl) benzoate derivatives and their photo switching ability.Liquid Crystals, 43(11), 1578-1588. [Impact factor: 2.244]
40. HegdeG, RajkumarYA, Mei GS, MahmoodS, Mandal UK, Sudhakar AA. (2016). hotoisomerization behavior of photochromic amide-based azobenzene dyes exhibiting H-bonding effect: Synthesis and characterization. Korean Journal of Chemical Engineering, 33(4), 1480-1488. [Impact factor: 1.170]
39. Elsayed TMA, Mandal UK, Kasmuri AR. (2015).Development of generic gliclazide 60 mg modified release tablets using central composite design.Latin American Journal of Pharmacy,34(8), 1516-1525.[Impact Factor: 0.372]
38. Mahmood S, Taher M, Mandal UK. (2014). Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. International Journal of Nanomedicine, 9, 4331-4346. [Impact Factor: 4.380]
37. Chaudhari SP, Bhise P, Lahane A, Misra M, Mandal U. (2010). Formulation and evaluation of thermoreversible mucoadhesive microemulsion based in-situ gel (TMMIG) of an anti-osteoporotic agent. Journal of Global Pharma Technology,2(10), 43-47.
36. Mandal U, Pal TK. (2008). Formulation and in-vitro studies of a fixed dose combination of bi-layer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.Drug Development and Industrial Pharmacy, 34(3), 305-313. [Impact Factor: 2.10]
35. Mandal U, Roy KK, Gowda V, Ghosh A, Pal TK. (2007). In-vitro and in-vivo correlation for two gliclazide extended release tablets.Journal of Pharmacy and Pharmacology, 59(7), 971-976. [Impact Factor: 2.26]
34. Sahoo BK, Gowda KV, Mandal U, Das A, Chakrabarty U, Pal TK. (2009). Sustained delivery of ranitidine HCl from floating matrix tablets: Formulation and in vitro evaluation. Asian Journal of Chemistry, 21 (2), 1350-1358. [Impact Factor: 0.45].
33. Ghosh A, Bhaumik U, Bose A, Mandal U, Gowda V, Chartterjee B, Chakraborty U, Pal TK. (2008). Extended release dosage form of glipizide: Development and validation of a Level A in vitro-in vivo correlation. Biological & Pharmaceutical Bulletin, 31(10), 1946-1951.[Impact Factor: 1.830]
32. Mandal U, Gowda VK, Ghosh A, Selvan PS, Solomon WDS, Pal TK. (2008). Development of dissolution medium for glipizide. Asian Journal of Chemistry, 20(4), 2651-2656. [Impact Factor: 0.45]
31. Mandal U, Gowda V, Ghosh A, Bose A, Bhaumik U, Chatterjee B, Pal TK. (2008). Optimization of Metformin HCl 500 mg sustained release matrix tablets using Artificial Neural Network (ANN) based on Multilayer Perceptrons (MLP) model. Chemical & Pharmaceutical Bulletin, 56(2), 150-155. [Impact Factor: 1.16]
30. Mandal U, Pal TK. (2008). Sustained release of metformin HCl from hydroxyl propyl methyl cellulose matrices: Formulation and in-vitro evaluation. Asian Journal of Chemistry, 20 (2), 1163-1174. [Impact Factor: 0.45]
29. Biswas SK, Mandal U, Pal TK. (2008). Formulation development and in vitro release kinetics of divalproex sodium sustained release matrix tablet.Asian Journal of Chemistry, 20(8), 5977-5985. [Impact Factor: 0.45]
28. MandalU, Gowda KV, Ghosh A, Selvan S, Solomon WDS, Pal TK. (2007). Formulation and optimization of sustained release matrix tablet of metformin HCl 500 mg using response surface methodology.Yakugaku Zasshi, 127(8), 1281-1290. [Impact Factor: 0.263]
27. Mandal U, Sarkar AK, Gowda KV, Agarwal S, Bose A, Bhaumik U, Ghosh D, Pal TK. (2008). Determination of pregabalin in human plasma by LC-MS-MS. Chromatographia, 67, 237-243.[Impact Factor:1.41]
26. Ghosh A, Bose A, Bhaumik U, Mandal U, Gowda KV, Pal TK. (2008). Application of Response Surface Methodology in the Formulation of Sustained Release Matrix Tablets of Metformin Hydrochloride. Asian Journal of Chemistry, 20 (7), 5541-5556. [Impact Factor: 0.45]
25. Bhaumik U, Ghosh A, Mandal U, Chatterjee B, Sarkar AK, Bose A, Ray KK, Pal TK. (2008). Determination of Drospirenone in Human Plasma by LC–Tandem-MS. Chromatographia, 68, 713-720. [Impact Factor: 1.41]
24. Sarkar AK, Ghosh D, Das A, Selvan PS, Gowda V, MandalU, Bose A, Agarwal S, Bhaumik U, Pal TK. (2008). Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography tandem mass spectrometry method and its application in bioequivalence study. Journal of Chromatography B, 873, 77-85. [Impact Factor: 2.73]
23. Solomon WDS, Gowda KV, Selvan PS, Mandal U, Pal TK. (2008). HPLC Method for Quantification of Ornidazole in Human Plasma. Asian Journal of Chemistry, 20(6), 4361-4368. [Impact Factor: 0.45]
22. Bhaumik U, Ghosh A, Chakrabarty U, Mandal U, Bose A, Das A, Roy KK, Pal TK. (2008). Evaluation of the bioequivalence of two faropenem formulations in healthy Indian subjects. Arzneimittel-Forschung Drug Research, 58(12), 681-685. [Impact Factor: 0.70]
21. Darbar S, Bose A, Chatterjee N, Roy B, Mandal U, Gowda KV, Ghosh A, Pal TK. (2008). Effect of Ascorbic Acid on Aceclofenac Induced Gastric Mucosal Damage: Role of Antioxidant Enzymes and Lipid Profile. Asian Journal of Chemistry, 20(7), 5567-5572. [Impact Factor: 0.45]
20. Chakrabarty US, Mandal U, Bhaumik U, Chatterjee B, Ghosh A, Bose A, Pal TK. (2008). Bioequivalence study of two capsule formulations containing diacerein 50 mg in healthy human subjects. Arzneimittel-Forschung Drug Research, 58(8), 405-409. [Impact Factor: 0.70]
19. Mandal U, Ghosh A, Pal TK, Chattaraj TK. (2008). Bioequivalence study of two formulations containing 30 mg of aripiprazole in healthy human volunteers. Asian Journal of Chemistry, 20(2), 1561-1566. [Impact Factor: 0.45]
18. Mandal U, Das A, Agarwal S, Chakraborty U, Nandi U, Chattaraj TK, Pal TK. (2008). Bioequivalence study of two formulations containing 400 mg dexibuprofen in healthy Indian subjects. Arzneimittel Forschung Drug Research, 58(7), 342-347. [Impact Factor: 0.70]
17. Selvan PS, Gowda KV, MandalU, Solomon WD, Pal TK. (2007). Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization- tandem mass spectrometry and its application to pharmacokinetic study.Journal of Chromatography B, 858, 269-275. [Impact Factor: 2.73]
16. Selvan PS, Gowda KV, MandalU, Solomon WDS, Pal TK. (2007). Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study.Journal of Chromatography B, 858, 143-150. [Impact Factor: 2.73]
15. GowdaKV, MandalU, Selvan PS, Solomon S, Ghosh A, Sarkar AK, Agarwal S, Rao TN, Pal TK. (2007). Liquid chromatography tandem mass spectrometry method for simultaneous determination of metoprolol tartarate and ramipril in human plasma.Journal of Chromatography B, 858, 13-21. [Impact Factor: 2.73]
14. Gowda KV, Rajan DS, Mandal U, Solomon WDS, Selvan PS, Bose A, Sarkar AK, Chattaraj TK, Pal TK. (2007). Bioequivalence study of fixed dose combination of Atorvastatin and Ezetimibe tablet in healthy volunteers by LC-MS/MS method. Asian Journal of Chemistry, 19(2), 1293-1300. [Impact Factor: 0.45]
13. Agarwal S, Gowda KV, Mandal U, Ghosh D, Bose A, Sarkar AK, Pal TK, Chattaraj TK. (2007). Analysis of pyridostigmine bromide in human plasma and its application in bioequivalence study. Journal of Liquid Chromatography and Related Technologies, 30(17), 2605-2615. [Impact Factor: 0.61]
12. Solomon WDS, Selvan PS, Gowda KV, Mandal U, Pal TK. (2007). Evaluation of bioequivalence of two formulations containing 200 mg of ketoconazole. Asian Journal of Chemistry, 19(7), 5365-5371. [Impact Factor: 0.45]
11. Agarwal S, Gowda KV, Mandal U, Ghosh D, Bose A, Sarkar AK, Chattaraj TK, Pal TK. (2007). Bioequivalence study of a sustained release fixed dose combination capsule containing esomeprazole and domperidone in healthy subjects. Arzneimittel-Forschung Drug Research, 57(5), 274-277.[Impact Factor: 0.70]
10. Gowda KV, Rajan DS,MandalU, Selvan PS, Sam Solomon WD, Bose A, Sarkar AK, Pal TK. (2006). Evaluation of bioequivalence of two formulations contain. (ing 100 mg of Aceclofenac.Drug Development & Industrial Pharmacy, 32, 1219-1225. [Impact Factor: 2.10]
9. Rajan DS, Gowda KV, Mandal U, Ganesan M, Bose A, Sarkar AK, Pal TK. (2006). Development of RP-HPLC for analysis of human insulin. Indian Journal of Pharmaceutical Sciences, 68(5), 662-665. [Impact Factor: 0.48].
8. Mandal U, Rajan DS, Bose A, Gowda KV, Ghosh A, Pal TK. (2006). Development and Validation of a HPLC method for analysis of Etoricoxib in human plasma. Indian Journal of Pharmaceutical Sciences, 68(4), 485-489. [Impact Factor: 0.48]
7. Mandal U, Jayakumar M, Ganesan M, Rajan DS, Pal TK, Gowda VK. (2005). Bioequivalence Study on quetiapine fumarate tablets by HPLC. Indian Drugs, 42(6), 353-356.
6. Rajan DS, Mandal UK, Gowda KV, Bose A, Ganesan M, Pal TK. (2004). Oral delivery system of insulin microspheres: effect on relative hypoglycaemia of diabetic albino rats. Bollettino Chimico Farmaceutica, 143, 315-318.
5. Mandal U, Jaykumar M, Ganesan M, Nandi S, Pal TK, Chakraborty M, Roychoudhury A, Chattoraj TK. (2004). Bioequivalence Study of Valdecoxib in Human Plasma by HPLC. Indian Drugs, 41(2), 91-96.
4. Mandal U, Musmade P, Ghosh A, Chakraborty M, Jayakumar M, Rajan DS, Chakravarti M, Pal TK, Chattaraj TK, Ray K, Banerjee SN. (2004). A study to determine the pharmacokinetics of Gatifloxacin following a single oral dose. Journal of the Indian Medical Association, 102(9), 488-490.
3. Mandal U, Musmade P, Chakraborty M, Rajan DS, Chakravarti M, Pal TK, Chattaraj TK. (2004). Bioequivalence Study of Sildenafil citrate tablets in healthy human volunteers. Bollettino Chimico Farmaceutica, 143, 345-349.
2. Mandal U, Ganesan M, Pal TK, Jayakumar M, Chattaraj TK, Ray K, Banerjee SN. (2004). Bioequivalence Study of Rabeprazole Sodium on Healthy Human Volunteers. Journal of the Indian Medical Association, 102(1), 26-30.
1. Mandal U, Ganesan M, Jaykumar M, Pal TK, Chattaraj TK, Ray K, Banerjee SN. (2003). High Performance Liquid Chromatographic Determination of COX-2 Inhibitior Rofecoxib in Human Plasma. Journal of the Indian Medical Association, 101(08), 486-488.
BOOK CHAPTERS:
7. Authored a chapter entitled “Preformulation and product development” in the book facturing of Halal Pharmaceuticals” edited by Dr. Kausar Ahmad, IIUM Press, Malaysia, 2015, Page 2-1 to 2-21. (ISBN: 979-967-418).
6. `Co-authored a chapter (Chapter 11) entitled “chitosan and alginate nanoparticles as oral insulin carrier” in the book entitled “Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities” edited by Eliana B. Souto, Springer-Verlag Berlin Heidelberg, 2012, Page 345-374.Authors: Wong TW, Mandal U, Li-JiuanS.(ISBN:978-3-642-29264-4).
5. Authored a chapter entitled “Development of an appropriate and robust dissolution method for solid dosage forms” in the book entitled “Pharmaceutical Technology Perspectives” edited by Muhammad Taher, IIUM Press, Malaysia. 2012, Page 116-125. (ISBN: 978-967-418-075-1).
4. Authored a chapter entitled “Pharmaceutical application of Solid Dispersion Technology in improving solubility of poorly soluble drugs: A review” in the book entitled “Current Issues in pharmacy” edited by Qamar Uddin Ahmed, IIUM Press, Malaysia. 2012, Page 157-177. (ISBN: 978-967-418-019-5).
3. Authored a chapter entitled “A recent updates of polysaccharide based nanoparticulate oral preparation of insulin with special emphasis on in-vivo application” in the book entitled “Pharmaceutical Technology Perspectives” edited by Muhammad Taher, IIUM Press, Malaysia. 2012, Page 97-115. (ISBN: 978-967-418-075-1).
2. Co-authored a chapter entitled “Bioequivalence of Gatifloxacin by HPLC Method- A Case Study” in the book entitled “Bioavailability and Bioequivalence in Pharmaceutical Technology” edited by Prof. (Dr.) Tapan Kumar Pal & Dr. M. Ganesan. CBS Publishers & Distributors, New Delhi.2004, Page 151-159. (ISBN: 978-812-391-158-8). Authors: Jayakumar M, MandalU and Pal TK.
1. Co-authored a chapter entitled “Bioequivalence Study under the purview of Clinical Trial” in the book entitled “Clinical Research - Practice & Prospects” edited by Prof. (Dr.) Tapan Kumar Pal & Sangita Agarwal. CBS Publishers & Distributors, New Delhi. 2009, Page 113-131. (ISBN: 978-812-391-685-9). Authors: Mandal U and Pal TK.
CONFERENCE PROCEEDINGS AS FULL PAPERS:
1. Senjoti FG, Jaffri JM, Mandal UK. (2014). Fabrication and optimization of gastro retentive drug delivery system with hpmc and polyethylene oxide (PEO) matrix. International Conference on Pharmaceutical Sciences and Biomedical and Chemical Engineering. 113-117. (ISBN No: 9788192710457).
1